Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
S P H Alexander, Helen E. Benson, Elena Faccenda, et al.
British Journal of Pharmacology (2013) Vol. 170, Iss. 8, pp. 1459-1581
Open Access | Times Cited: 552

Showing 1-25 of 552 citing articles:

Microglial M1/M2 polarization and metabolic states
Rubén Orihuela, Christopher A. McPherson, G. Jean Harry
British Journal of Pharmacology (2015) Vol. 173, Iss. 4, pp. 649-665
Open Access | Times Cited: 1589
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor
Robert B. Laprairie, Amina M. Bagher, Michael E. Kelly, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 20, pp. 4790-4805
Open Access | Times Cited: 862
The contribution of astrocytes and microglia to traumatic brain injury
Ila Prasad Karve, Juliet M. Taylor, Peter J. Crack
British Journal of Pharmacology (2015) Vol. 173, Iss. 4, pp. 692-702
Open Access | Times Cited: 569
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
Pertti Panula, Paul L. Chazot, Marlon Cowart, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 3, pp. 601-655
Open Access | Times Cited: 504
Movers and shakers: cell cytoskeleton in cancer metastasis
Christopher M. Fife, Joshua A. McCarroll, Maria Kavallaris
British Journal of Pharmacology (2014) Vol. 171, Iss. 24, pp. 5507-5523
Open Access | Times Cited: 503
Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
John M. McPartland, Marnie Duncan, Vincenzo Di Marzo, et al.
British Journal of Pharmacology (2014) Vol. 172, Iss. 3, pp. 737-753
Open Access | Times Cited: 473
Dopamine receptors – IUPHAR Review 13
Jean‐Martin Beaulieu, Stefano Espinoza, Raul R. Gainetdinov
British Journal of Pharmacology (2014) Vol. 172, Iss. 1, pp. 1-23
Open Access | Times Cited: 454
Neuropeptide Y: A stressful review
Florian Reichmann, Peter Holzer
Neuropeptides (2015) Vol. 55, pp. 99-109
Open Access | Times Cited: 414
Sex differences in animal models of psychiatric disorders
Nikolaos Kokras, Christina Dalla
British Journal of Pharmacology (2014) Vol. 171, Iss. 20, pp. 4595-4619
Open Access | Times Cited: 389
Amylin: Pharmacology, Physiology, and Clinical Potential
Debbie L. Hay, Steve Chen, Thomas A. Lutz, et al.
Pharmacological Reviews (2015) Vol. 67, Iss. 3, pp. 564-600
Open Access | Times Cited: 318
Lysophospholipid receptor nomenclature review: IUPHAR Review 8
Yasuyuki Kihara, Michael Maceyka, Sarah Spiegel, et al.
British Journal of Pharmacology (2014) Vol. 171, Iss. 15, pp. 3575-3594
Open Access | Times Cited: 309
Progressive inflammation‐mediated neurodegeneration after traumatic brain or spinal cord injury
Alan I. Faden, Junfang Wu, Bogdan A. Stoica, et al.
British Journal of Pharmacology (2015) Vol. 173, Iss. 4, pp. 681-691
Open Access | Times Cited: 249
Complex Pharmacology of Free Fatty Acid Receptors
Graeme Milligan, Bharat Shimpukade, Trond Ulven, et al.
Chemical Reviews (2016) Vol. 117, Iss. 1, pp. 67-110
Open Access | Times Cited: 247
Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
Magnus Bäck, William S. Powell, Sven‐Erik Dahlén, et al.
British Journal of Pharmacology (2014) Vol. 171, Iss. 15, pp. 3551-3574
Open Access | Times Cited: 203
IL‐1β and IL‐18: inflammatory markers or mediators of hypertension?
Shalini M Krishnan, Christopher G. Sobey, Eicke Latz, et al.
British Journal of Pharmacology (2014) Vol. 171, Iss. 24, pp. 5589-5602
Open Access | Times Cited: 197
Therapeutic targets of triple‐negative breast cancer: a review
Vinayak Jamdade, Nikunj Sethi, Nitin Mundhe, et al.
British Journal of Pharmacology (2015) Vol. 172, Iss. 17, pp. 4228-4237
Open Access | Times Cited: 187
Opioid Analgesia and Opioid-Induced Adverse Effects: A Review
Alok Kumar Paul, Craig M. Smith, Mohammed Rahmatullah, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 11, pp. 1091-1091
Open Access | Times Cited: 146
WNT/Frizzled signalling: receptor–ligand selectivity with focus on FZD‐G protein signalling and its physiological relevance: IUPHAR Review 3
Jacomijn P. Dijksterhuis, Julian Petersen, Gunnar Schulte
British Journal of Pharmacology (2013) Vol. 171, Iss. 5, pp. 1195-1209
Open Access | Times Cited: 169
Biased signalling and proteinase‐activated receptors (PARs): targeting inflammatory disease
Morley D. Hollenberg, Koichiro Mihara, Danny Polley, et al.
British Journal of Pharmacology (2013) Vol. 171, Iss. 5, pp. 1180-1194
Open Access | Times Cited: 168
Ketamine and phencyclidine: the good, the bad and the unexpected
David Lodge, Marion Mercier
British Journal of Pharmacology (2015) Vol. 172, Iss. 17, pp. 4254-4276
Open Access | Times Cited: 166
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti‐inflammatory agent
Francesca Borrelli, Barbara Romano, Stefania Petrosino, et al.
British Journal of Pharmacology (2014) Vol. 172, Iss. 1, pp. 142-158
Open Access | Times Cited: 158
High‐fat diet‐induced metabolic disorders impairs 5‐HT function and anxiety‐like behavior in mice
Juliane Zemdegs, Gaël Quesseveur, David Jarriault, et al.
British Journal of Pharmacology (2015) Vol. 173, Iss. 13, pp. 2095-2110
Open Access | Times Cited: 155
Prostaglandin E2 and the EP receptors in malignancy: possible therapeutic targets?
Grace O’Callaghan, Aileen Houston
British Journal of Pharmacology (2015) Vol. 172, Iss. 22, pp. 5239-5250
Open Access | Times Cited: 155
Activation of GPR18 by cannabinoid compounds: a tale of biased agonism
Linda Console‐Bram, Eugen Brailoiu, G. Cristina Brailoiu, et al.
British Journal of Pharmacology (2014) Vol. 171, Iss. 16, pp. 3908-3917
Open Access | Times Cited: 146
Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant properties
Béatrice Guardiola‐Lemaître, Christian de Bodinat, Philippe Delagrange, et al.
British Journal of Pharmacology (2014) Vol. 171, Iss. 15, pp. 3604-3619
Open Access | Times Cited: 145
Page 1 - Next Page

Scroll to top